Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs
Author:
Affiliation:
1. Division of Gastroenterology & Liver Unit; University of Alberta Hospital; Edmonton; AB; Canada
2. Division of Gastroenterology & Hepatology; Mayo Clinic College of Medicine; Rochester; MN; USA
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12042/fullpdf
Reference148 articles.
1. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis;Czaja;Gastroenterology,2010
2. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis;Cook;Q J Med,1971
3. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis;Soloway;Gastroenterology,1972
4. Controlled trial of prednisone and azathioprine in active chronic hepatitis;Murray-Lyon;Lancet,1973
5. American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis;Manns;Hepatology,2010
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cyclophosphamide in refractory autoimmune hepatitis and autoimmune hepatitis coexisting extrahepatic autoimmune disorders: A review;The American Journal of the Medical Sciences;2024-06
2. Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview;Diagnostics;2024-02-09
3. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial;Trials;2024-01-17
4. PD-L1 expression levels in mesenchymal stromal cells predict their therapeutic values for autoimmune hepatitis;Stem Cell Research & Therapy;2023-12-18
5. Tacrolimus versus mycophenolate for autoimmune hepatitis patients with incomplete response on first line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial;2023-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3